Completed NA INTERVENTIONAL 2-arm NCT03309137

Device for Bacteremia Prevention in Post Cardiac Surgical Intensive Care Unit Patients (CHG-Lock™)

CHG-Lock™ Device for Bacteremia Prevention in Cardiac Surgical Intensive Care Unit Patients: An Open Label Randomized Feasibility Pilot Study

Sponsor: Alison Fox-Robichaud

Conditions Bacteremia Heart; Surgery, Heart, Functional Disturbance as Result Infection

Interventions Chlorhexidine flush

Updated 8 times since 2017 Last updated: May 3, 2022 Started: Nov 19, 2017 Primary completion: Nov 30, 2020 Completion: Nov 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03309137, this NA trial focuses on Bacteremia and Heart; Surgery, Heart, Functional Disturbance as Result and remains completed. Sponsored by Alison Fox-Robichaud, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Oct 2021 — Jun 2022 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Aug 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Aug 2019 [monthly]

Not Yet Recruiting NA
Oct 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alison Fox-Robichaud
Dr. Julian Owen
Dr. Richard Whitlock
Pamela Benoit, RN

Data source: Hamilton Health Sciences Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada